Ignite Creation Date:
2024-05-06 @ 2:40 AM
Last Modification Date:
2024-10-26 @ 11:22 AM
Study NCT ID:
NCT02109016
Status:
TERMINATED
Last Update Posted:
2019-07-29
First Post:
2014-04-07
Brief Title:
A Study to Assess the Efficacy and Safety of the VEGFR-FGFR Inhibitor Lucitanib Given to Patients With AdvancedMetastatic Lung Cancer and FGF VEGF or PDGF Related Genetic Alterations
Sponsor:
Clovis Oncology Inc
Organization:
Clovis Oncology Inc
Organization Data
Organization:
Clovis Oncology Inc
Class:
INDUSTRY
Study ID:
E-3810-II-02
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Clovis Oncology Inc
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None